Accretion nutraveda limited IPO Overview
Accretion nutraveda limited IPO is a SME public issue offered through a Fixed Price issue with a total issue size of ₹25 Cr. The IPO price band is set at ₹122 to ₹129 per share, and retail investors can apply with a minimum investment of ₹2.58 L as per IPO guidelines.
The Accretion nutraveda limited IPO opens on 28 Jan 2026 and closes on 30 Jan 2026. The IPO allotment is expected to be finalized on 2 Feb 2026, and the equity shares are proposed to be listed on BSE on 4 Feb 2026.
Investors can refer to the Accretion nutraveda limited IPO RHP-DRHP for detailed information. The issue is managed by Sobhagya Capital Options Pvt.Ltd as the book running lead manager, while Kfin Technologies Limited is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About accretion nutraveda limited
The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.
Investment Objective
2 Purchase of Machineries for New Manufacturing Setup
3 Funding working capital requirements of our company
4 General corporate purposes